Quantessence Capital’s Delcath Systems DCTH Stock Holding History

Quantessence Capital’s Portfolio DCTH Stock Details DCTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-17,330	Closed	-$221K	–	251
2025 Q1	$221K	Buy	+17,330	New	+$246K	0.06%	268

Other funds holding DCTH

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Quantessence Capital's DCTH Position: Q2 2025 in Review

Quantessence Capital sold out of Delcath Systems (DCTH) in Q2 2025, closing a stake of 17,330 shares — an estimated $221K sold.

Quantessence Capital first reported a position in DCTH in Q1 2025 and held it in 1 quarter. The position peaked at $221K in Q1 2025. 117 funds tracked by Wall St. Rank hold DCTH as of Q2 2025.

Quantessence Capital reported no remaining Delcath Systems position as of Q2 2025 after selling out during the quarter.
Quantessence Capital sold 17,330 Delcath Systems shares in Q2 2025, an estimated $221K.
Quantessence Capital first reported a position in Delcath Systems in Q1 2025 and held it in 1 quarter.
Quantessence Capital's Delcath Systems position peaked at $221K in Q1 2025.
117 funds tracked by Wall St. Rank held Delcath Systems as of Q2 2025.

Based on Quantessence Capital's 13F filing for Q2 2025, filed 14 Aug 2025.